JOFABYO

Serial Number 79255008
Registration 5999137
700

Registration Progress

Application Filed
Feb 1, 2019
Under Examination
Approved for Publication
Dec 17, 2019
Published for Opposition
Dec 17, 2019
Registered
Mar 3, 2020

Attorney Assistance

Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200303)
Due: Mar 03, 2026 77 days

Trademark Image

JOFABYO

Basic Information

Serial Number
79255008
Registration Number
5999137
Filing Date
February 1, 2019
Registration Date
March 3, 2020
Published for Opposition
December 17, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 3, 2020
Registration
Registered
Classes
005

Rights Holder

Idorsia Pharmaceuticals Ltd

99
Address
Hegenheimermattweg 91
CH-4123 Allschwil
CH

Ownership History

Idorsia Pharmaceuticals Ltd

Original Applicant
99
CH

Idorsia Pharmaceuticals Ltd

Owner at Publication
99
CH

Idorsia Pharmaceuticals Ltd

Original Registrant
99
CH

Legal Representation

Attorney
Mary Margaret L. O'Donnell

USPTO Deadlines

Next Deadline
77 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200303)
Due Date
March 03, 2026
Grace Period Ends
September 03, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Mar 3, 2025 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Dec 11, 2020 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jul 24, 2020 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jul 8, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jul 8, 2020 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jun 3, 2020 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Mar 3, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 17, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 17, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 27, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 12, 2019 ALIE A ASSIGNED TO LIE Loading...
Nov 6, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 5, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 4, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 4, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 4, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 4, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 25, 2019 RFNT P REFUSAL PROCESSED BY IB Loading...
May 7, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 7, 2019 RFRR P REFUSAL PROCESSED BY MPU Loading...
Apr 14, 2019 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Apr 13, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 13, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 2, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 28, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 21, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, neurodegenerative diseases, neurological disorders, anxiety, addictions including addictive eating disorders, and neurodegenerative disorders including Alzheimer's disease, diseases of the central nervous system, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, and allergic diseases

Classification

International Classes
005